Sera Prognostics - IR Website

Home

News

Month Year

Investor Alerts

March 03

SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...

Read More
February 17

SERA PROGNOSTICS PRESENTATION RESCHEDULED FOR CITI 2022 HEALTHCARE CONFERENCE

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...

Read More
February 07

SERA PROGNOSTICS TO PRESENT AT UPCOMING FEBRUARY INVESTOR CONFERENCES

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...

Read More
December 15

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...

Read More
December 02

SERA PROGNOSTICS ANNOUNCES PRICING FOR PRETRM® TEST, THE ONLY BROADLY VALIDATED BLOOD TEST TO ASSESS RISK OF PRETERM BIRTH

– New Assigned Rate Further Validates the Commercial Value of the PreTRM® Test –

Salt Lake City – Dec 2, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

Read More

Show per page

Email Alerts